Sleep Apnea, Obstructive Completed Phase 2 Trials for Dalfampridine (DB06637)

IndicationStatusPhase
DBCOND0030275 (Sleep Apnea, Obstructive)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02656160Effect of Dalfampridine (4-AP) on Genioglossus Muscle Activity in Healthy AdultsTreatment